Pathogenesis, Assessment, and Treatment of Coronary Microcirculation Dysfunction
- PMID: 39230107
- PMCID: PMC11495817
- DOI: 10.36660/abc.20230767
Pathogenesis, Assessment, and Treatment of Coronary Microcirculation Dysfunction
Abstract
Cardiovascular disease is the predominant cause of mortality on a global scale. Research indicates that women exhibit a greater likelihood of presenting with non-obstructive coronary artery disease (CAD) when experiencing symptoms of myocardial ischemia in comparison to men. Additionally, women tend to experience a higher burden of symptoms relative to men, and despite the presence of ischemic heart disease, they are frequently reassured erroneously due to the absence of obstructive CAD. In cases of ischemic heart disease accompanied by symptoms of myocardial ischemia but lacking obstructive CAD, it is imperative to consider coronary microvascular dysfunction as a potential underlying cause. Coronary microvascular dysfunction, characterized by impaired coronary flow reserve resulting from functional and/or structural abnormalities in the microcirculation, is linked to adverse cardiovascular outcomes. Lifestyle modifications and the use of anti-atherosclerotic and anti-anginal medications may offer potential benefits, although further clinical trials are necessary to inform treatment strategies. This review aims to explore the prevalence, underlying mechanisms, diagnostic approaches, and therapeutic interventions for coronary microvascular dysfunction.
A doença cardiovascular é a causa predominante de mortalidade em escala global. A pesquisa indica que as mulheres, em comparação aos homens, apresentam maior probabilidade de apresentar doença arterial coronariana (DAC) não obstrutiva quando têm sintomas de isquemia miocárdica. Além disso, as mulheres tendem a apresentar uma maior carga de sintomas em relação aos homens e, apesar da presença de doença cardíaca isquêmica, são frequentemente tranquilizadas erroneamente devido à ausência de DAC obstrutiva. Nos casos de cardiopatia isquêmica acompanhada de sintomas de isquemia miocárdica, mas sem DAC obstrutiva, é imperativo considerar a disfunção microvascular coronariana como uma potencial causa subjacente. A disfunção microvascular coronariana, caracterizada por reserva de fluxo coronariano prejudicada resultante de anormalidades funcionais e/ou estruturais na microcirculação, está associada a desfechos cardiovasculares adversos. Modificações no estilo de vida e o uso de medicamentos antiateroscleróticos e antianginosos podem oferecer benefícios potenciais, embora sejam necessários mais ensaios clínicos para informar estratégias de tratamento. Esta revisão tem como objetivo explorar a prevalência, mecanismos subjacentes, abordagens diagnósticas e intervenções terapêuticas para disfunção microvascular coronariana.
Conflict of interest statement
Não há conflito com o presente artigo
Similar articles
-
Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.Nat Rev Cardiol. 2015 Jul;12(7):406-14. doi: 10.1038/nrcardio.2015.72. Epub 2015 May 26. Nat Rev Cardiol. 2015. PMID: 26011377 Review.
-
Sex Differences in the Coronary System.Adv Exp Med Biol. 2018;1065:257-278. doi: 10.1007/978-3-319-77932-4_17. Adv Exp Med Biol. 2018. PMID: 30051390 Free PMC article. Review.
-
Reappraisal of Ischemic Heart Disease.Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373. Circulation. 2018. PMID: 30354347 Review.
-
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.J Am Coll Cardiol. 2019 Feb 19;73(6):684-693. doi: 10.1016/j.jacc.2018.11.040. J Am Coll Cardiol. 2019. PMID: 30765035 Free PMC article.
-
Current perspectives in coronary microvascular dysfunction.Microcirculation. 2017 Jan;24(1). doi: 10.1111/micc.12340. Microcirculation. 2017. PMID: 27976459 Review.
References
-
- Aribas E, van Lennep JER, Elias-Smale SE, Piek JJ, Roos M, Ahmadizar F, et al. Prevalence of Microvascular Angina among Patients with Stable Symptoms in the Absence of Obstructive Coronary Artery Disease: A Systematic Review. Cardiovasc Res. 2022;118(3):763–771. doi: 10.1093/cvr/cvab061. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous